Research articles
Top 10 Biopharma Companies by Market Cap: September 2023 vs. 2024
Biotech IPO Trifecta: A Resurgence of Innovation and Investment
Post-Keytruda: Potential Growth Drivers for Merck
ESMO 2024: Recap of Notable Advances in Oncology
Select Eli Lilly U.S. Patent Expiries
Moderna's Strategic Shift: Paving the Way for Diversification and Profitability
Q2 2024 Revenue and Growth Across Ten Major Biopharma Companies
